Indian Drugmaker Taps Private Credit for Japanese Acquisition
Indian drugmaker Gujarat Themis Biosyn Ltd. has obtained private credit funding to back its purchase of Japanese peer MicroBiopharm Japan Co., highlighting the growing use of such debt for overseas expansion in Asia.
This is a short extract from a report by Bloomberg. The full text stays with the publisher — follow the link to read it there.
Read at source